The Tumor Environment in Peritoneal Carcinomatosis and Malignant Pleural Effusions: Implications for Therapy. [PDF]
Mirsky PO +4 more
europepmc +1 more source
Auger Emitting [<sup>161</sup>Tb]Tb-PSMA-617 Radioligand Therapy in mCRPC with Peritoneal Carcinomatosis. [PDF]
Rosar F +7 more
europepmc +1 more source
Peritoneal tuberculosis mimicking peritoneal carcinomatosis in a patient with T-cell lymphoma: Diagnostic pitfalls and radiologic correlation. [PDF]
Bassel SA +5 more
europepmc +1 more source
The Interleukin-8-CXCR1/2 Axis as a Therapeutic Target in Peritoneal Carcinomatosis. [PDF]
Sherry C +9 more
europepmc +1 more source
Inflammatory Markers may Determine Postoperative Complications in Cases of Peritoneal Carcinomatosis of Ovarian Origin Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. [PDF]
Mustafa D +6 more
europepmc +1 more source
Evaluation of the Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) on Long-Term Survival and Morbidity Profile: A Systematic Review of the Peritoneal Carcinomatosis Management. [PDF]
Sarmiento Bonilla CI +8 more
europepmc +1 more source
Efficacy of Bidirectional Paclitaxel plus Capecitabine or Nilotinib for Peritoneal Carcinomatosis: A Single Institution Analysis of Two Phase II Clinical Trials. [PDF]
Gallanis AF +20 more
europepmc +1 more source
Diagnostic Pitfalls in Peritoneal Carcinomatosis: A Case of Pseudomyxoma Peritonei. [PDF]
Isachanka M +8 more
europepmc +1 more source
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Recurrent Endometrial Cancer With Peritoneal Carcinomatosis. [PDF]
Lolis ED +3 more
europepmc +1 more source
Comparative Performance of <sup>68</sup> Ga-FAPI-04 and <sup>18</sup> F-FDG PET/CT in Ovarian Cancer: Focus on Peritoneal Carcinomatosis. [PDF]
Arslan E +7 more
europepmc +1 more source

